Cargando…

The contribution of Parkin, PINK1 and DJ‐1 genes to selective neuronal degeneration in Parkinson's disease

Parkinson's disease (PD) is characterised by selective and severe degeneration of the substantia nigra pars compacta and the locus coeruleus (LC), which underlies the most prominent symptoms. Although α‐synuclein accumulation has long been established to play a causal role in the disease, it al...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Vlag, Marc, Havekes, Robbert, Heckman, Pim R. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496448/
https://www.ncbi.nlm.nih.gov/pubmed/31991026
http://dx.doi.org/10.1111/ejn.14689
_version_ 1783583099070709760
author van der Vlag, Marc
Havekes, Robbert
Heckman, Pim R. A.
author_facet van der Vlag, Marc
Havekes, Robbert
Heckman, Pim R. A.
author_sort van der Vlag, Marc
collection PubMed
description Parkinson's disease (PD) is characterised by selective and severe degeneration of the substantia nigra pars compacta and the locus coeruleus (LC), which underlies the most prominent symptoms. Although α‐synuclein accumulation has long been established to play a causal role in the disease, it alone cannot explain the selective degenerative pattern. Recent evidence shows that the selective vulnerability could arise due to the large presence of cytosolic catecholamines and Ca(2+) ions in the substantia nigra pars compacta and LC specifically that can be aberrantly affected by α‐synuclein accumulation. Moreover, each has its own toxic potential, and disturbance of one can exacerbate the toxic effects of the others. This presents a mechanism unique to these areas that can lead to a vicious degenerative cycle. Interestingly, in familial variants of PD, the exact same brain areas are affected, implying the underlying process is likely the same. However, the exact disease mechanisms of many of these genetic variants remain unclear. Here, we review the effects of the PD‐related genes Parkin, PINK1 and DJ‐1. We establish that these mutant varieties can set in motion the same degenerative process involving α‐synuclein, cytosolic catecholamines and Ca(2+). Additionally, we show indications that model organisms might not accurately represent all components of this central mechanism, explaining why Parkin, PINK1 and DJ‐1 model organisms often lack a convincing PD‐like phenotype.
format Online
Article
Text
id pubmed-7496448
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-74964482020-09-25 The contribution of Parkin, PINK1 and DJ‐1 genes to selective neuronal degeneration in Parkinson's disease van der Vlag, Marc Havekes, Robbert Heckman, Pim R. A. Eur J Neurosci Clinical and Translational Neuroscience Parkinson's disease (PD) is characterised by selective and severe degeneration of the substantia nigra pars compacta and the locus coeruleus (LC), which underlies the most prominent symptoms. Although α‐synuclein accumulation has long been established to play a causal role in the disease, it alone cannot explain the selective degenerative pattern. Recent evidence shows that the selective vulnerability could arise due to the large presence of cytosolic catecholamines and Ca(2+) ions in the substantia nigra pars compacta and LC specifically that can be aberrantly affected by α‐synuclein accumulation. Moreover, each has its own toxic potential, and disturbance of one can exacerbate the toxic effects of the others. This presents a mechanism unique to these areas that can lead to a vicious degenerative cycle. Interestingly, in familial variants of PD, the exact same brain areas are affected, implying the underlying process is likely the same. However, the exact disease mechanisms of many of these genetic variants remain unclear. Here, we review the effects of the PD‐related genes Parkin, PINK1 and DJ‐1. We establish that these mutant varieties can set in motion the same degenerative process involving α‐synuclein, cytosolic catecholamines and Ca(2+). Additionally, we show indications that model organisms might not accurately represent all components of this central mechanism, explaining why Parkin, PINK1 and DJ‐1 model organisms often lack a convincing PD‐like phenotype. John Wiley and Sons Inc. 2020-02-06 2020-08 /pmc/articles/PMC7496448/ /pubmed/31991026 http://dx.doi.org/10.1111/ejn.14689 Text en © 2020 The Authors. European Journal of Neuroscience published by Federation of European Neuroscience Societies and John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Clinical and Translational Neuroscience
van der Vlag, Marc
Havekes, Robbert
Heckman, Pim R. A.
The contribution of Parkin, PINK1 and DJ‐1 genes to selective neuronal degeneration in Parkinson's disease
title The contribution of Parkin, PINK1 and DJ‐1 genes to selective neuronal degeneration in Parkinson's disease
title_full The contribution of Parkin, PINK1 and DJ‐1 genes to selective neuronal degeneration in Parkinson's disease
title_fullStr The contribution of Parkin, PINK1 and DJ‐1 genes to selective neuronal degeneration in Parkinson's disease
title_full_unstemmed The contribution of Parkin, PINK1 and DJ‐1 genes to selective neuronal degeneration in Parkinson's disease
title_short The contribution of Parkin, PINK1 and DJ‐1 genes to selective neuronal degeneration in Parkinson's disease
title_sort contribution of parkin, pink1 and dj‐1 genes to selective neuronal degeneration in parkinson's disease
topic Clinical and Translational Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496448/
https://www.ncbi.nlm.nih.gov/pubmed/31991026
http://dx.doi.org/10.1111/ejn.14689
work_keys_str_mv AT vandervlagmarc thecontributionofparkinpink1anddj1genestoselectiveneuronaldegenerationinparkinsonsdisease
AT havekesrobbert thecontributionofparkinpink1anddj1genestoselectiveneuronaldegenerationinparkinsonsdisease
AT heckmanpimra thecontributionofparkinpink1anddj1genestoselectiveneuronaldegenerationinparkinsonsdisease
AT vandervlagmarc contributionofparkinpink1anddj1genestoselectiveneuronaldegenerationinparkinsonsdisease
AT havekesrobbert contributionofparkinpink1anddj1genestoselectiveneuronaldegenerationinparkinsonsdisease
AT heckmanpimra contributionofparkinpink1anddj1genestoselectiveneuronaldegenerationinparkinsonsdisease